Advanced-Flow Reactor installed to help center of excellence advance India’s pharmaceutical industry
Hyderabad, India – Corning Incorporated today announced that it will join the Flow Chemistry Technology (FCT) Hub at Dr. Reddy’s Institute of Life Sciences (DRILS) – a not-for-profit research institute in India, focused on accelerating adoption of flow chemistry in the Indian pharmaceutical industry. The FCT Hub will use Corning’s G1 reactor platform as one of their research, training, and education tools to help industry scientists, researchers, and students embark on knowledge and capability advancements through the Hub’s teaching and training program.
The FCT Hub was established in collaboration with the Government of Telangana State, Dr. Reddy’s Laboratories, Laurus Labs, and DRILS in May 2022. This Hub is designed to develop and hone scientific capabilities to meet and advance the needs of the chemical manufacturing industry in India. The FCT Hub brings together multiple capabilities – from chemistry and engineering leaders – to choose the right reactions and help pharmaceutical and biotech companies prioritize products and technologies to address challenges in translating existing processes to continuous manufacturing solutions.
“Incorporating Corning into the DRILS collaboration promises to unlock a variety of opportunities for the FCT Hub by enabling safer handling of inherently hazardous chemical reactions while optimizing reaction kinetics to achieve ultra-fast chemistries,” said Dr. Srinivas Oruganti, director of DRILS. “We believe that this exceptional alliance will enable the creation of groundbreaking initiatives while simultaneously fostering learning and development in a conducive environment, aligning with the core values and objectives of DRILS.”
Designed for early-stage reactions, Corning Advanced-Flow Reactor’s (AFR) G1 reactor platform enables energy savings, increased efficiency of chemical synthesis, and lower production costs.
“Corning is committed to the education of students and industry partners to help realize the advantages of continuous flow chemistry using AFR’s inherently safer technology,” said Sudhir Pillai, managing director, Corning India. “Today, most of the top 20 active pharmaceutical ingredient manufacturers in India have either deployed or tested Corning’s AFR Technology. And we believe joining the Flow Chemistry Technology Hub will continue to advance the pharmaceutical industry in India.”
Today, India is increasingly called “the pharmacy for the world” and is home to a rapidly growing pharmaceutical market, placing it at the forefront of the global life sciences industry. India plays an important role in the global pharmaceuticals sector, supplying more than 50% of global demand for a variety of vaccines, 40% of generic medicine demand in the U.S., and 25% of all medicine in the U.K. according to IBEF’s 2022 Pharmaceuticals Industry Report. Corning’s AFR technology provides a variety of solutions to help meet the needs of small and large laboratories as well as industrial-scale manufacturing to support continued growth in the region.
Registration is now open for the flow-chemistry training workshops, which will be conducted by the FCT Hub in June, August, October, and December in 2023. For more information on these training workshops, please reach out to fct-hub@drils.org.
